These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Evaluation of the effectiveness of chemoradiotherapy of stage IIIA Hodgkin's disease].
    Author: Kanaev SV, Gershanovich ML, Malinin AP, Kholin AV.
    Journal: Med Radiol (Mosk); 1987 May; 32(5):16-21. PubMed ID: 3586917.
    Abstract:
    A total of 106 case histories of primary patients with stage III Hodgkin's disease aged 15 and older were analyzed. The treatment consisted of 2 introductory courses of polychemotherapy after MOPP scheme followed by a radical program of radiotherapy in 2-4 weeks, resulting in 88.7% of complete remissions. The 5-year survival rate was 81.3-6.3%, a 5-year recurrence-free course was noted in 83.8-5.2%. The 5-year survival rate was significantly lower in the patients with "unfavorable" histological types (mixed cellular and lymphoid depletion). A recurrence-free course over the same period was worse in men than in women, and in the patients with 5 and more zones of involvement.
    [Abstract] [Full Text] [Related] [New Search]